KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Halozyme Therapeutics (HALO) Times Interest Earned (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Times Interest Earned for 13 consecutive years, with -$18.91 as the latest value for Q4 2025.

  • Quarterly Times Interest Earned fell 148.93% to -$18.91 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $25.87 through Dec 2025, down 15.1% year-over-year, with the annual reading at $25.87 for FY2025, 15.1% down from the prior year.
  • Times Interest Earned for Q4 2025 was -$18.91 at Halozyme Therapeutics, down from $50.73 in the prior quarter.
  • The five-year high for Times Interest Earned was $53.11 in Q2 2021, with the low at -$18.91 in Q4 2025.
  • Average Times Interest Earned over 5 years is $26.69, with a median of $25.87 recorded in 2021.
  • The sharpest move saw Times Interest Earned skyrocketed 4384.26% in 2021, then plummeted 148.93% in 2025.
  • Over 5 years, Times Interest Earned stood at $27.51 in 2021, then crashed by 40.74% to $16.3 in 2022, then grew by 18.72% to $19.36 in 2023, then skyrocketed by 99.72% to $38.66 in 2024, then tumbled by 148.93% to -$18.91 in 2025.
  • According to Business Quant data, Times Interest Earned over the past three periods came in at -$18.91, $50.73, and $46.07 for Q4 2025, Q3 2025, and Q2 2025 respectively.